Biochemistry, Genetics and Molecular Biology
Amino Acids
20%
Asparagine
100%
Biogenesis
100%
Body Weight
16%
C-Terminus
86%
Cell Cycle
50%
Cell Cycle Progression
100%
Cell Death
33%
Cell Growth
16%
Cell Survival
16%
Cyclin B
16%
DNA Damage Response
16%
EHD1
80%
Embryogenesis
16%
Exon
33%
Fibroblast
100%
G1 Phase
16%
G2 Phase
16%
Glutamic Acid
100%
Glycerophospholipid
20%
Histone H3
16%
Knockout Mouse
33%
Lentivirus
16%
Lipid
20%
LoxP Site
16%
Mammalian Cell
20%
Membrane Lipid
20%
Morphology
16%
Mouse
100%
Mouse Model
16%
Paralogy
20%
Phosphatase
83%
Phosphatidic Acid
40%
Phospholipase D
20%
Protein Domain
20%
Protein Expression
16%
RNA Polymerase II
16%
S Phase
16%
Splice Site Mutation
16%
Keyphrases
Aberrant Expression
18%
Activity Growth
9%
Aggressive Phenotype
9%
Atomic Mechanism
8%
Basal-like
9%
Conformational Epitope
9%
Disease Progression
9%
Epidermal Growth Factor
9%
Epidermal Growth Factor Receptor
100%
ErbB Receptors
9%
Essential Lipids
8%
Facial Neuropathy
20%
Gemcitabine
9%
Glycoform
9%
Glycogen Synthase Kinase 3 (GSK3)
9%
Haloacid Dehalogenase Superfamily
20%
Immunotherapeutics
9%
Locomotive Function
20%
Membrane Vesiculation
8%
Metastasis
9%
Monoclonal Antibody
36%
MUC16
100%
MUC16/CA125
9%
O-glycosylation
9%
Oncogenic Activity
9%
Oncogenic Signaling
100%
Pancreatic Cancer
100%
Pancreatic Duct Cells
9%
Pancreatic Ductal Adenocarcinoma
45%
Pancreatic Tumorigenesis
9%
Parameter Function
20%
Phospholipase D Inhibitor
8%
Short-term Survival
9%
Tumor Growth
18%
Tumor Malignancy
18%
Tumor Metastasis
18%
Tumor Subtype
9%
Tumor-bearing Mice
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carcinogenesis
16%
Disease Exacerbation
16%
Epidermal Growth Factor
16%
Epidermal Growth Factor Receptor
100%
Epitope
16%
Gemcitabine
16%
Immunomodulating Agent
16%
Metastasis
33%
Monoclonal Antibody
66%
Mouse
16%
Neoplasm
66%
Pancreas Adenocarcinoma
100%
Pancreas Cancer
100%
Short Term Survival
16%
Tumor Growth
33%